Moshe Sarfaty
Chief Executive Officer at LS Biopath, Inc.
Moshe Sarfaty active positions
Companies | Position | Start | End |
---|---|---|---|
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Director/Board Member | - | - |
Chief Executive Officer | 2008-12-31 | - | |
President | - | - | |
Aristagora VC Israel Management Ltd. | Private Equity Investor | 2020-06-30 | - |
Career history of Moshe Sarfaty
Former positions of Moshe Sarfaty
Companies | Position | Start | End |
---|---|---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Founder | 2012-12-31 | 2020-07-01 |
Training of Moshe Sarfaty
Yale University | Undergraduate Degree |
Statistics
International
Israel | 3 |
United States | 3 |
Operational
Founder | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Finance | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Finance |
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Health Technology |
Aristagora VC Israel Management Ltd. | Finance |
- Stock Market
- Insiders
- Moshe Sarfaty
- Experience